E-LIB Suche - Ergebnisse für: Cardin, Dana

1

Trends in the Incidence and Treatment of Early-Onset Pancre..:

LaPelusa, Michael ; Shen, Chan ; Arhin, Nina D....
Cancers. 14 (2022) 2 - p. 283 , 2022

Link: https://doi.org/10.3390/..

2

Targeting DNA Damage Repair Pathways in Pancreatic Adenocar..:

Das, Satya ; Cardin, Dana
Current Treatment Options in Oncology. 21 (2020) 8 - p. , 2020

Link: https://doi.org/10.1007/..

3

Harnessing the Immune System in Pancreatic Cancer:

Das, Satya ; Berlin, Jordan ; Cardin, Dana
Current Treatment Options in Oncology. 19 (2018) 10 - p. , 2018

Link: https://doi.org/10.1007/..

4

Tu1953 Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone..:

Tempero, Margaret ; Cardin, Dana ; Biankin, Andrew V....
Gastroenterology. 148 (2015) 4 - p. S-944 , 2015

Link: https://doi.org/10.1016/..

5

Safety and Efficacy of Avelumab in Small Bowel Adenocarcino..:

Cardin, Dana B. ; Gilbert, Jill ; Whisenant, Jennifer G....
Clinical Colorectal Cancer. 21 (2022) 3 - p. 236-243 , 2022

Link: https://doi.org/10.1016/..

6

First-in-human phase I/II, open-label study of the anti-OX4..:

Davis, Elizabeth J ; Martin-Liberal, Juan ; Kristeleit, Rebecca...
Journal for ImmunoTherapy of Cancer. 10 (2022) 10 - p. e004235 , 2022

Link: https://doi.org/10.1136/..

7

Pancreatic Cancer in Young Adults: Can Innovative Approache..:

Cardin, Dana B ; Eng, Cathy
JNCI: Journal of the National Cancer Institute. 113 (2021) 9 - p. 1125-1126 , 2021

Link: https://doi.org/10.1093/..

8

Clinical Activity and Safety of Cediranib and Olaparib Comb..:

Kim, Joseph W. ; Cardin, Dana B. ; Vaishampayan, Ulka N....
The Oncologist. 26 (2021) 7 - p. e1104-e1109 , 2021

Link: https://doi.org/10.1002/..

9

A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Effic..:

Roth, Marc T. ; Cardin, Dana Backlund ; Borazanci, Erkut Hasan...
The Oncologist. 25 (2020) 10 - p. e1446-e1450 , 2020

Link: https://doi.org/10.1634/..

10

Recent advances in the treatment of pancreatic cancer:

Roth, Marc T ; Cardin, Dana B ; Berlin, Jordan D
F1000Research. 9 (2020) - p. 131 , 2020

Link: https://doi.org/10.12688..

11

Immune-Related Adverse Events and Immune Checkpoint Inhibit..:

Das, Satya ; Ciombor, Kristen K. ; Haraldsdottir, Sigurdis...
The Oncologist. 25 (2020) 8 - p. 669-679 , 2020

Link: https://doi.org/10.1634/..

12

Advanced pancreatic cancer clinical trials: The continued u..:

White, Maya N. ; Dotan, Efrat ; Catalano, Paul J...
Journal of Geriatric Oncology. 10 (2019) 4 - p. 540-546 , 2019

Link: https://doi.org/10.1016/..

13

A phase 1b dose escalation study of Wnt pathway inhibitor v..:

Davis, S. Lindsey ; Cardin, Dana B. ; Shahda, Safi...
Investigational New Drugs. 38 (2019) 3 - p. 821-830 , 2019

Link: https://doi.org/10.1007/..

14

Dual Src and EGFR inhibition in combination with gemcitabin..:

Cardin, Dana B. ; Goff, Laura W. ; Chan, Emily...
Investigational New Drugs. 36 (2017) 3 - p. 442-450 , 2017

Link: https://doi.org/10.1007/..

15

Phase II study of the Multikinase inhibitor of angiogenesis..:

Chan, Emily ; Goff, Laura W. ; Cardin, Dana B....
Investigational New Drugs. 35 (2017) 4 - p. 491-498 , 2017

Link: https://doi.org/10.1007/..